25
Mar

COVID-19 Fact Sheet - Advice for businesses and organisations

This COVID-19 Fact Sheet provides information and advice for...

27
Feb

Quality Diagnostic Pathology Supporting Medical Research

Does long-term exposure to mobile phones decrease amyloid de...

25
Feb

EUCAST Guidelines

SA Pathology uses guidelines from the European Committee on ...

31
Jan

2019 – Pathology in Review

Demand for pathology services is increasing; in 2019 SA Path...

24
Jan

iPath

SA Pathology is pleased to announce the arrival of iPath, a ...

Clinician News

Omega-3 status testing now available

21 April 2021

SA Pathology now provides testing omega-3 levels for women with singleton pregnancies, with the data informing the South Australian Health and Medical Research Institute (SAHMRI)’s world-leading study assessing the efficacy of omega-3 supplementation in reducing early preterm births.

Requesting providers may offer the omega-3 status test to all women with singleton pregnancies before 20 weeks’ gestation. SA Pathology and SAHMRI perform Omega-3 analysis at no cost to the patient or health service using serum collected as part of the established SAMSAS program.

For further information about omega-3 testing and results interpretation, please visit sahmri.org/omega3 or call the omega-3 status test hotline on 0438 273 155.

To order the maternal serum screening test request form, please call the SAMSAS Program on (08) 8161 7285.